Related pages Drug Information Summaries Approval Process for New Cancer Treatments Access to Investigational Drugs

This page contains brief information about toremifene and a collection of links to more information about the use of this drug and ongoing clinical trials.

US Brand Name(s):		Fareston
FDA Approved:		Yes

Toremifene is approved by the Food and Drug Administration (FDA) to treat breast cancer in postmenopausal women whose cancer has metastasized (spread to other parts of the body). It is used when the cancer is estrogen receptor positive (ER+) or when it is not known if the cancer is ER+ or estrogen receptor negative (ER-).

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Targeted Cancer Therapies - Information about the use of this drug to treat cancer.

MedlinePlus Information on Toremifene - A lay language summary of important information about this drug that may include the following:

• warnings about this drug,
• what this drug is used for and how it is used,
• what you should tell your doctor before using this drug,
• what you should know about this drug before using it,
• other drugs that may interact with this drug, and
• possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This NLM patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Clinical Trials for Toremifene - Check for trials from NCI's PDQ Cancer Clinical Trials Registry now accepting patients.

Back to Top